PURPOSE
To provide the best available evidence in care of patients with chronic wounds.
TARGET AUDIENCE
This continuing education activity is intended for physicians, and nurses with an interest in wound care. OBJECTIVES After reading this article and taking this test, the reader should be able to: 1. Identify local factors and recommendations for preparing the wound bed, including DIME and MEASURE, and ways to promote patient adherence to the treatment plan. 2. Explain impairments and time guidelines to wound healing, problems with wound healing, and types of wound pain. T he concept of Preparing the wound bed was first described in 2000 by Sibbald et al. and Falanga. 1, 2 This approach to wound management stresses that successful diagnosis and treatment of patients with chronic wounds require holistic care and a team approach. The whole patient must be considered before looking at the wound itself. Figure 1 illustrates that wound bed preparation is the promotion of wound closure through diagnosis and appropriate treatment of the cause, attention to patient-centered concerns, and correction of the systemic and local factors that may be delaying healing.
The guidelines that are important for local wound care include: 1. Registered Nurses' Association of Ontario (RNAO) Nursing Best Practice Guideline: Assessment and Management of Foot Ulcers for People with Diabetes (2005). 3 
Registered Nurses' Association of Ontario (RNAO) Nursing
Best Practice Guideline: Assessment and Management of Venous Leg Ulcers (2004). 4 3. Anti-infective Guidelines for Community Acquired Infections (2005) . 5 
IDENTIFY AND TREAT THE CAUSE Recommendation 1: (Level of Evidence: IV)
Assess the patient's ability to heal. Adequate blood supply must be present, as well as the correction of other important host factors to support healing.
Discussion
There are several important factors that determine the patient's ability to heal. The patient must be assessed to determine if the blood supply is adequate to support healing. If a regional pulse can be palpated, the local arterial flow will usually support healing. If the dorsalis pedis pulse is present, there is approximately 80 mm of mercury (Hg) or higher pressure. The radial pressure can be palpated at 70 mm Hg and the carotid at 60 mm Hg. If a pulse cannot be felt, special studies may include Doppler to assess the ankle-brachial pressure index or toe pressures. In specialized centers such as hyperbaric facilities, transcutaneous oxygen saturation equipment is often available. Benchmark values that indicate potential to heal include ABPI over 0.5 with a biphasic or triphasic pattern, toe pressure of 50 mm Hg or greater and transcutaneous oxygen pressure 
PREPARING THE WOUND BED PARADIGM
Adapted from Sibbald RG, Orsted HL, Schultz GS, et al. 6 The Canadian Association of Wound Care (CAWC) best practice articles are not comprehensive but are meant to provide a practical, easy-to-follow guide or bedside enabler for patient care. The recommendations are based on the best available evidence and are intended to support the wound care clinician and team in planning and delivering the best clinical practice. For more detailed information, refer to the following RNAO Nursing Best Practice Guidelines or the designated references. over 30 mm Hg. Below these levels, healing may still occur if all other contributing factors are optimized ( Table 2 ). Clinicians must remember that in the presence of calcified arteries an ankle-brachial pressure index may be falsely elevated and any value over 1.2 is likely due to calcified vessels, unless proven otherwise. Remember that the ability to heal and the criteria to apply compression are different. An ABPI will give information on arterial blood supply, but the diagnosis of venous disease must be based on clinical parameters and special duplex Doppler evaluation of the venous system.
Once the presence of adequate arterial flow is established, other criteria that may influence the healablilty of chronic ulcers must be examined: & A careful Drug history (and known allergies) should be obtained. Immunosuppressive agents and systemic steroids can impair healing. & Uncontrolled Edema can impair healing. The area around a chronic wound should be examined, and edema, if present, needs to be corrected. Cleanse wounds with low-toxicity solutions (such as normal saline or water). Topical antiseptic solutions should be reserved for wounds that are nonhealable or those in which the local bacterial burden is of greater concern than the stimulation of healing.
III 8
Assess and treat the wound for increased bacterial burden or infection (distinguish from persistent inflammation of nonbacterial origin).
IIa 9
Select a dressing that is appropriate for the needs of the wound, the patient, and the caregiver or clinical setting. IV 10
Evaluate expected rate of wound healing. If suboptimal, reassess recommendations 1 to 9.
III-IV 11
Use active wound therapies (biological agents, skin grafts, adjunctive therapies) when other factors have been corrected and healing still does not progress.
Ia-IV
Provide Organizational Support  12 For improved outcomes, education and evidence base must be tied to interprofessional teams with the cooperation of health care systems. 
IV

Recommendation 2: (Level of Evidence: IV)
Diagnose and correct or modify treatable causes of tissue damage.
Discussion
It is important to treat the cause of an ulcer as outlined in other articles of this series in Wound Care Canada. & Pressure ulcers require pressure redistribution and attention to other cofactors, such as friction, shear, mobility, nutrition, and control of external moisture, including feces. & Venous ulcers require edema control, with the cornerstone being compression therapy and activity modifications to activate the calfmuscle pump. & Persons with diabetic foot ulcers require pressure offloading and appropriate control of diabetes and its complications, including infection.
There are personal and health care system factors that may prevent adequate correction of the cause. When it is not possible to provide best practice, clinicians may consider treating the wound to prevent complications and to improve quality of life rather than have healing as the primary outcome. Enoch and Price 8 ask us to consider alternate endpoints to healing. This type of wound can be referred to as a ''maintenance'' wound. If the goal is not wound healing, it is important to use resources to support alternate endpoints, such as quality of life (through care support) and prevention of complications (through specialty surfaces), rather than as wound-healing resources (dressings). The RNAO Assessment and Management guidelines 3, 4 outline the importance of not just practice recommendations but also recommendations relating to educational and operational needs.
ADDRESS PATIENT-CENTERED CONCERNS
Recommendation 3: (Level of Evidence: IV)
Assess and support the management of patient-centered concerns (pain and quality of life) to enable healing.
Discussion
Unresolved pain can negatively affect wound healing which, in turn, has a negative impact on quality of life. 9 Pain can cause activation of the sympathetic branch of the autonomic nervous system, leading to tissue hypoxia. Pain can also stimulate the hypothalamic-pituitary-adrenal axis, causing a release of cortisol. Both impact negatively on wound healing. Experienced clinicians need to take an initial full pain history to provide information about the patient's pain experience, with ongoing pain assessment occurring at each patient visit.
There are two types of pain: nociceptive (an appropriate physiological response to painful stimuli [acute or chronic]) and neuropathic (an inappropriate response caused by a primary lesion or dysfunction in the nervous system). The World Union of Wound Healing Societies (WUWHS) Consensus Panel on pain identified categories related to the cause of pain (Table 3) that, in turn, support the development of management strategies for pain control. Psychological factors, such as age, sex, culture, anxiety, and depression, as well as environmental factors, such as resources, the setting, and the timing of the procedure can all affect the patient's pain experience. Describing pain and monitoring the impact of management strategies for pain control begins by listening to how the patient describes the pain. Pain intensity can be measured using tools, such as a visual faces scale or numerical rating scale, and pain frequency (and intensity) can be monitored using a pain diary. The World Health Organization (WHO) originally developed the pain ladder to simplify the management of cancer pain, but it is now used in a more generalized fashion ( Figure 2 ). 10 The ladder provides a treatment algorithm that recommends a step-wise approach to alleviating persistent pain. Each progressive step on the ladder represents medications with higher potency for increased severity of pain. The WHO ladder, however, does not take into account neuropathic pain. Patients with neuropathic pain need to be referred to a specialist who is able to diagnose and treat neuropathic pain. 9 Neuropathic pain is often identified with nonstimulus dependent, burning, stinging, shooting, and stabbing pain. It can be treated with tricyclic antidepressants, especially agents that have high antinoradrenalin activity such as nortriptyline or desipramine. Gabapentin will also treat neuropathic pain. These agents can be started in a low dose with a gradual increase in dosage that balances therapeutic effect and side effects. Chronic wound pain often benefits from combining treatment for nociceptive and neuropathic pain.
Recommendation 4: (Level of Evidence: IV)
Provide education and support for patient-centered care to increase adherence with a treatment plan.
Discussion
In the 2000 article, 1 the focus was on patient compliance to health care provider recommendations, briefly touching on the term adherence. Adherence has become the cornerstone of patient-centered care, providing an open dialogue for patients and clinicians to discuss the rationale for care and its impact on the patient's life. The word adherence is preferred by many health care providers, because compliance suggests that the patient is passively following the health care provider's orders and that the treatment plan is not based on a therapeutic relationship established between the patient and the provider. Osterberg and Blaschke state that, ''Poor adherence to medication regimens is common, contributing to substantial worsening of disease, death, and increased health care Table 3 .
CAUSES AND MANAGEMENT OF PAIN
Causes of Pain Characteristics Management Strategies
Background pain Pain at rest (related to wound etiology, infection, ischemia)
Treat the underlying etiology of the wound and associated pathologies. Provide analgesic and nonanalgesic options per WHO Pain Ladder.
Incident pain
Pain during day-to-day activities (coughing, friction, dressing slippage)
Procedural pain Pain from routine procedures (dressing removal, application)
Preparation and planning of the procedure are key to preventing pain. Analgesics per WHO Pain Ladder should be administered before a procedure and may be required post procedure. Dressing selection is key to pain management with dressing removal and application.
Operative pain
Pain associated with an intervention that would require an anaesthetic (cutting of tissue or prolonged manipulation) Figure 2 .
WHO PAIN LADDER
Reprinted with permission from the World Health Organization. 10 costs.'' 11 They recommend that, during patient visits, practitioners look for indications of poor adherence by asking the patient how easy it has been to follow the treatment plan and by assessing clinical response to treatment, pill counts/rates of refill, and physiologic markers. Support for adherence to treatment regimens can occur in several ways, but appears most effective when several strategies are used in combination: 1. Emphasize the value of the patient's regimen and the positive effects of adherence. 2. Make the patient's regimen simple with simple, clear instructions. 3. Listen to the patient and customize the regimen to their lifestyle. 4. Enlist support from family, friends, and community services when needed. Health care interventions that incorporate a nonjudgemental attitude as well as a collaborative approach to care augment patient adherence. Innovative methods of managing chronic diseases have had some success in improving adherence when a regimen has been difficult to follow. New technologies, such as reminders through cell phones and personal digital assistants and pillboxes with paging systems, may be needed to help patients who have the most difficulty meeting the goals of a regimen.
PROVIDE LOCAL WOUND CARE
The Preparing the Wound Bed Paradigm in Figure 1 illustrates a holistic approach to caring for a person with a wound. Table 4 focuses on the components of local wound care and emphasizes the expected outcomes from clinical actions.
Recommendation 5: (Level of Evidence: IV)
Assess and monitor the wound history and physical characteristics (location + MEASURE).
Discussion
Consistent and reliable wound assessment remains a clinical challenge for wound care clinicians. Wound assessment must include a global assessment of the patient and the environmental factors that may affect wound healing, as well as local assessment of the wound itself (see Figure 3 ). The MEASURE 13 mnemonic presented in Table 5 is a simple conceptual framework that may act as a basis for a consistent approach to local wound assessment. The most common parameters evaluated include size, wound edges, wound bed appearance, presence or absence of undermining, exudate, and pain. When assessed at an appropriate frequency, these parameters give the clinician important decision-making information and create a comprehensive wound history. Clinicians are reminded that local wound assessment must occur in the context of a global assessment of the patient and of the environment.
Change in wound surface area is emerging as the most reliable predictor of outcomes in wound healing. The challenge is to measure wound surface areas in a valid and reliable manner. Consistently done, simple ruler methods may be adequate for most clinical practice settings, but for greater reliability, acetate tracings or digitizing systems should be considered.
Regardless, wound assessments need to be consistently done and documented in the patient record. Multiple wound assessment tools have been developed to assist the clinician. The tool selected for use should be both valid and reliable and should detect change over time. In 1999, Woodbury et al 14 critically appraised the tools existing at the time. The PSST (also known as the BWAT) and Sessing tools showed the best evidence for their use with pressure ulcers. Since that time, further work on validation of the PUSH tool 15 has been completed, and it can be recommended for use. The PWAT 16 tool is useful for all types of ulcers and can be scored reliably from 35 mm photographs. Most recently, the Leg Ulcer Measurement Tool (LUMT) 17 has been validated for use with leg ulcers. The tool used must be appropriate for the setting and the users. 18 found evidence to support hydrogels over standard gauze, but concluded that there was insufficient evidence for surgical or larval (biologic) therapy. The Steed 19 retrospective analysis, not considered in the Cochrane review, does, however, provide good evidence (Level Ib) for surgical debridement of neuropathic ulcers with adequate circulation to heal. Table 6 has been adapted from the one included in the original paper 1 to include larval (biologic) debridement therapy. This table assists the clinician in choosing the appropriate method of debridement based on key clinical factors. Many clinicians are reluctant to perform debridement, especially in primary care settings, because of the perceived risks. 20 Before clinicians embark on debridement of chronic wounds they must ensure that they have the necessary skills to perform the task, the skill is within their scope of practice, and there is agency or institutional policy in place to support them. The discussions of autolytic, mechanical, and surgical debridement in the original article remain current.
Enzymatic debridement uses proteolytic agents to break down necrotic tissue. Various commercial preparations containing agents, such as collagenase, papain/urea, DNAse/ fibrinolysin, and trypsin, are available in different countries. In general, these agents are safe and specific to necrotic tissue but may cause local irritation due to pH changes. They may provide for faster removal of necrotic tissue than autolysis.
Except for collagenase, very little literature exists on their efficacy. One study showed collagenase to be more costeffective than hydrocolloids in the treatment of Stage IV pressure ulcers. 21 In another study, collagenase was shown to be more effective than other enzymatic debriding agents and mechanical debridement in the form of wet-to-dry dressings. 22 In some countries, noncommercial preparations may be used. 23 Only collagenase has been approved for use in Canada.
Larval debridement therapy, or biological debridement, is gaining in popularity in many clinical settings. In this therapy, sterile larvae of the greenbottle fly (Lucilia sericata) are used to remove nonviable tissue from the wound bed. Proteinases secreted by the larvae selectively digest nonviable tissue. 24 Several recent studies have appeared in the literature supporting the use of larval debridement therapy. 24, 26 Concern remains regarding infection if nonsterile larvae are used. 27 This method has yet to find general acceptance in Canada largely because of ''patient and clinician disgust'' but when presented in an appropriate manner may find more acceptance. 28 Recommendation 7: (Level of Evidence: III) Cleanse wounds with low-toxicity solutions (such as normal saline or water). Topical antiseptic solutions should be reserved for wounds that are nonhealable or those in which the local bacterial burden is of greater concern than the stimulation of healing.
In vitro studies have identified the toxicity of many of the topical antiseptic agents as outlined in the previous review (see Table 7 ). 1, 6 To prevent tissue damage, in wounds with the ability to heal, saline and water are recommended as cleansing agents. If a wound is nonhealable and bacterial burden is more important than tissue toxicity, antiseptics may be used to dry the wound surface and decrease local bacterial proliferation. This strategy may also be important if deep infection or osteomyelitis is present. Once the deep infection has been controlled, toxic solutions should not be instituted, and moist interactive dressings will promote healing and optimal preparation of the wound bed.
Recommendation 8: (Level of Evidence: IIa)
Discussion
The diagnosis of infection is based on clinical criteria, with bacterial swabs or deep cultures, and laboratory and radiological tests used as adjuncts for diagnosis and treatment. All wounds contain bacteria at levels ranging from contamination through colonization and critical colonization (also known as increased bacterial burden, occult or covert infection) to infection. Increased bacterial burden may be confined to the superficial wound bed or may be present in the deep compartment and surrounding tissue of the wound margin. Therefore, it becomes important to diagnose both the bacterial imbalance and the level of invasion in order to diagnose and treat infection properly (Table 8 ). Increased bacterial burden in pressure ulcers has been demonstrated to delay healing in patients with chronic ulceration. 29, 30 Contamination is the presence of bacteria in the wound surface, and colonization is the presence of replicating bacteria attached to the wound tissue, but not causing injury to the host. Critical colonization occurs when bacteria delay or stop healing of the wound without the presence of classical symptoms and signs of infection. Infection is the presence of replicating microorganisms in a wound associated with host injury. The borders between these concepts are not clearly established. The clinician must assess the patient's symptoms and signs present in the wound to distinguish contamination, colonization, and healing from critically colonized or infected wounds that are not healing or that even may be endangering the life of the patient.
The classical signs of infections are pain, erythema, edema, purulent discharge and increased warmth. In chronic wounds, other signs of infection should be added. These include delayed healing or new areas of breakdown, increased discharge (often initially serous or clear and watery before it becomes pustular), bright red discolouration of granulation tissue, friable and exuberant granulation, new areas of slough on the wound surface, undermining, and a foul odor. 31 Serous exudate may be increased in a chronic wound with increasing bacterial burden before purulence is noted, with the clinical signs usually recognized in infections. It has been suggested that chronic wounds should show some evidence of healing within four weeks to progress to healing by week 12. 13 If this time limit is exceeded, then increased bacterial burden or infection should be suspected as one of the causes of delayed healing. 32 Discolouration of granulation tissue arises from loose, poorly formed granulation tissue, while friable granulation tissue that bleeds easily occurs from excessive angiogenesis stimulated by bacterial pathogens. Healthy granulation tissue is pink-red and moist with a translucent appearance. When infected, it will appear dull and may have patches of greenish or yellow discolouration. Certain anaerobic species, such as Bacteroides fragilis and Streptococci, produce a dullish, dark red hue, while Pseudomonas may produce green or blue patches that may fluoresce at 365 nm (Wood's) light.
Undermining results from atrophic granulation tissue inhibited or digested by bacteria. Foul odor is usually produced by gram-negative bacilli, especially Pseudomonas species or anaerobes, digesting granulation tissue. 33 Deep infection will often cause erythema and warmth extending 2 cm or more beyond the wound margin when the surrounding skin becomes involved. The bacterially stimulated increased inflammatory response is painful and will cause the wound to increase in size or lead to satellite areas of tissue breakdown resulting in adjacent tissue ulceration. Deep infections, especially in ulcers of long duration, can often lead to underlying osteomyelitis. Probing to bone is a simple clinical test that may indicate osteomyelitis, especially in patients with neuropathic foot ulcers often associated with diabetes. 34 Gardner et al 35, 36 If topical antimicrobials are used, it is important to use nonsensitizing antibiotics with low tissue toxicity. Agents used systemically should be avoided to prevent breeding resistant organisms on the surface of a wound (Table 9 ). Common sensitizers frequently misused in patients with chronic wounds, particularly leg ulcers, are antibiotics, such as neomycin and bacitracin, or agents containing lanolin or perfumes. 39 For systemic antibiotics, it is often wise to base choices on culture once a diagnosis is made. In chronic wounds of less than one month in duration, the causative pathogens are often gram-positive organisms. For wounds of greater than one month in duration or in patients who are immunecompromised, broad spectrum coverage for gram-positives, gram-negatives, and anaerobic species is usually required (see Table 10 ).
Recommendation 9: (Level of Evidence: IV)
Select a dressing that is appropriate for the needs of the wound, the patient, and the caregiver or clinical setting.
Discussion
Clinicians should base the choice of dressing selection on the patient history and assessment, the cause of the wound, and the evaluation of the wound bed and periwound skin. Each wound must be treated individually as there is no ''recipe'' for a particular wound type. The selected dressing should provide the appropriate moisture for the wound environment, prevent infection, not cause pain, and not cause damage to the wound or periwound area. The clinician needs to consider what the function of the dressing is in order to maximize the preparation of the wound bed. The form chosen needs to conform to the area where it is applied to facilitate moisture balance and prevent infection. Ongoing reassessment of the dressing choice needs to occur along with the regular assessment of the wound.
The clinician should become familiar with the different categories of dressings and their construction (Table 12 ). They should have an understanding of the mode of action of the dressing within the wound, as well as the indications and contraindications to use. The selection of the dressing should balance the goal of care with the cost to payer in order to attain optimal, cost-effective care.
Recommendation 10: (Level of Evidence: III-IV)
Evaluate expected rate of wound healing to determine if treatment is optimal. If suboptimal healing is noted, reassess the cause and patient-centered concerns.
Discussion
Flanagan 41 states that a 20 percent to 40 percent reduction of wound area in two and four weeks is likely to be a reliable predictive indicator of healing. A clinical study demonstrated that a 50 percent reduction in ulcer area at 12 weeks of treatment is a good predictor of healing. 42 If the edge is not migrating, and the wound is not getting smaller, a full reassessment of cause and corrective therapies needs to occur. If patient and wound factors are optimized and the edge is still not migrating, then a wound may need advanced therapies to kick-start the healing process. A biopsy to rule out other causes, such as unrecognized malignancy, needs to occur if healing does not progress. Falanga 2 designed a classification system (Table 11 ) to monitor the outcomes of bioengineered skin that is helpful in assessing the movement of the wound edge as a parameter for monitoring healing outcomes.
Clinicians need to remember that the edge of the wound is only one outcome parameter, and wound closure is not always the expected outcome. Maintenance wounds, that is wounds that are unlikely to heal, need to have alternative endpoints, such as wound stabilization, reduced pain, reduced bacterial load, or decreased frequency of dressing changes. 8
Recommendation 11: (Level of Evidence: Ia-IV)
Discussion
Adjunctive therapies should be considered as options for wound management when healing is recalcitrant. Adjunctive 44 have reviewed the use of NPWT in the Canadian context. Both reports were unable to find significant evidence to support the use of NPWT but did conclude that there were clear clinical situations where the use of NPWT might be beneficial. These included such benefits as earlier hospital discharge, fewer dressing changes, savings in nursing costs, and improved quality of life. The Canadian Consensus Group also suggested appropriate criteria for implementing NPWT. These included appropriate assessment of the patient, the absence of fistulas and malignancy, the ability of the patient to adhere to the plan of care, and at least four weeks of prior first-line treatment without a reasonable decrease in wound size (<30%).
A 2004 Cochrane review by Kranke et al 45 gave qualified support to the use of hyperbaric oxygen treatment (HBOT) for diabetic foot ulcers. HBOT significantly reduced the risk of major amputation and may improve the chance of healing at one year. The authors commented on the high cost of the therapy and its limited availability. The review could find no evidence to support the use of HBOT in other etiologies.
Cochrane reviews of the use of both electromagnetic therapy 46 and low-level laser 47 in the treatment of venous leg ulcers could find no evidence to support these modalities. This is consistent with the findings regarding pressure ulcers discussed in the pressure ulcer paper in this issue.
The discussion of the use of living skin equivalents and of plateletderived growth factor from the original 2000 Preparing the wound bed article remains valid. 1 A recent meta-analysis of artificial skin grafts done for the Canadian Co-ordinating Office for Health Technology Assessment 48 concluded that artificial skin grafts promote wound closure, resulting in more frequent and rapid healing of diabetic foot ulcers when compared to standard therapy. The effect was seen 11 to 12 weeks after application of the graft. The same effect was not seen in venous leg ulcers. No significant increase in adverse For improved outcomes, education and evidence base must be tied to interprofessional teams with the cooperation of health care systems.
Wound healing can be a complex process once all the factors and cofactors that may affect healing are identified. Best practice care for persons with chronic ulcers demands a systematic, team approach from knowledgeable and skilled health care professionals. These team members will vary based on the needs of the patients. The interdisciplinary team needs to work closely with patients and their families to address the complex lifestyle, self-care, and multiple treatment demands of patients who have chronic wounds. Clinicians can facilitate and positively influence wound healing outcomes by promoting, collaborating, and participating in interdisciplinary care teams who follow best practice guidelines similar to those presented in this document and the other documents in this series. Armstrong et al 49 demonstrated that a team approach to diabetic foot care resulted in significant savings to the health care system. Implementation of best-practice, team-focused care in a study of 16,000 patients resulted in 66 percent fewer hospital admissions, a 74 percent decrease in hospital days, and a 53 percent decrease in nursing home admissions. The development and implementation of a successful wound management program not only involve collaboration with practice leaders but, as the RNAO guidelines demonstrate, also benefit from collaboration with educators and administrators. Their support is required to ensure coordinated care with community and health care agencies and the specialized, knowledgeable interdisciplinary team of health care professionals striving for improved wound care outcomes. All the RNAO wound-care-related clinical practice guidelines contain multiple recommendations related to the value of interprofessional teams and the need for organizational support.
CONCLUSION
The concept of the Preparing the wound bed algorithm as a systematic clinical decision-making framework, first published in the 2000 article, has stood the test of time. 1 The key components of wound assessment and management, i.e., identifying and treating the cause of the wound, addressing patient-centered concerns, establishing goals for wound healing, optimizing local wound care, and collaborating with interprofessional team members, remain valid five years later. To effect change and improve healing outcomes, clinicians need to move beyond the local to the global, learning to interact with, and effect change within, health care systems.
